ChartMill is a comprehensive online stock research platform designed to empower traders and investors with advanced tools for technical and fundamental analysis. The company provides a robust stock screener that allows users to filter thousands of stocks across major exchanges like NYSE, NASDAQ, and EURONEXT, using over 180 customizable technical and fundamental parameters to identify trading opportunities.
Heron Therapeutics reported mixed Q3 2025 results, missing revenue and earnings estimates. Despite strong growth from its Acute Care products, the miss led to a negative market reaction.
Core Molding Tech (CMT) shares fell after missing Q3 2025 earnings and revenue estimates. The company also lowered its full-year sales guidance, citing a challenging market.
Great Lakes Dredge & Dock (GLDD) Q3 2025 earnings beat estimates by 50%, driving shares up. Strong profitability and a $934M backlog signal a positive outlook for 2026.
Expeditors International (EXPD) beat Q3 2025 earnings estimates with strong airfreight and customs results, despite challenges in the ocean freight market.
Delcath Systems reported Q3 2025 revenue below estimates but met earnings targets. The interventional oncology firm showed strong product growth and clinical progress.
Oxford Square Capital (OXSQ) reported Q3 2025 results with revenue beating estimates. NAV per share rose to $2.92, and it declared steady distributions for early 2026.
AG Mortgage Investment Trust (MITT) reported mixed Q3 2025 results, beating earnings estimates but missing on revenue. The REIT also increased its stake in Arc Home.
Hamilton Lane (HLNE) Q2 FY2026 earnings beat analyst forecasts, with revenue of $190.88M and EPS of $1.54, driving a positive pre-market stock reaction.
TPG's Q3 2025 results show strong operational growth with record capital deployment, but revenue and earnings per share fell short of Wall Street estimates.
AdaptHealth (AHCO) Q3 2025 earnings beat revenue estimates but missed on EPS. The stock rose as investors focused on the revenue beat and strong operational progress.
Hagerty (HGTY) Q3 earnings crush estimates, with a 60% EPS beat. The company raises its full-year 2025 outlook, projecting strong revenue and profit growth.
Yum! Brands Q3 2025 earnings beat EPS estimates, but revenue slightly missed. The stock rose as the company announced a strategic review for Pizza Hut and strong Taco Bell growth.
Amicus Therapeutics (FOLD) beats Q3 2025 earnings estimates with strong revenue growth and a major milestone in profitability, driving positive market momentum.
Chicago Atlantic (REFI) reported mixed Q3 2025 results, beating EPS estimates with $0.49 but missing revenue forecasts. The cannabis industry lender showed profit strength despite a top-line shortfall.
DAVE INC (DAVE) smashed Q3 2025 earnings forecasts, posting record revenue and a huge EPS beat. The strong results, driven by user growth, sent the stock soaring.
LGI Homes Q3 2025 results show a slight revenue beat but a significant earnings miss. The homebuilder's stock fell as investor focus remained on declining profits and a cautious outlook.
Madrigal's Q3 2025 earnings show Rezdiffra sales of $287.3M, crushing estimates. With over 29,500 patients on therapy, the stock surged on strong commercial uptake.
OCULAR THERAPEUTIX reported mixed Q3 2025 results, with a slight revenue miss but a narrower-than-expected loss. The company highlighted progress in its AXPAXLI clinical pipeline.
Kodiak Gas Services (KGS) is a technical breakout candidate with strong momentum, trading above key moving averages and forming a consolidation pattern.
Orthofix (OFIX) Q3 2025 earnings beat estimates with $0.20 EPS vs. $(0.41) forecast. Revenue of $205.6M also surpassed expectations, driven by strong spine and orthopedics growth.
Verastem's Q3 2025 results show a strong revenue beat from its new cancer drug launch, while its net loss widened. The stock dipped slightly on the mixed earnings news.
Driven Brands (DRVN) beat Q3 2025 profit estimates with EPS of $0.34. Revenue of $535.7M slightly missed forecasts. The stock rose on strong earnings and improved leverage.
Silicon Labs (SLAB) Q3 2025 results show mixed performance with revenue slightly below estimates but a beat on EPS, driving a positive pre-market stock reaction.
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.
Lantheus Holdings (LNTH) appears undervalued with strong fundamentals. Its low P/E ratio, robust profitability, and healthy balance sheet make it a compelling value investing candidate.
Marzetti Company (MZTI) reported record Q1 earnings and revenue, beating analyst estimates with strong performance in both Retail and Foodservice segments.
ADT Q3 2025 earnings: Revenue slightly missed estimates, but profit beat forecasts. The company also narrowed its full-year guidance and highlighted strong cash flow.
Vital Farms (VITL) Q3 2025 earnings beat estimates with revenue of $198.9M and EPS of $0.36. The stock surged over 8% as the company raised its full-year outlook.
Bowhead Specialty Holdings (BOW) beat Q3 earnings estimates with strong premium growth and a 30.9% jump in investment income, despite a slight stock dip.
Rhythm Pharmaceuticals posts mixed Q3 2025 results, missing revenue estimates. Despite the loss, the company highlights strong drug growth and key regulatory milestones for its obesity treatments.
Taysha Gene Therapies stock fell after Q3 results, with a revenue miss overshadowing positive FDA Breakthrough Therapy designation for its Rett syndrome drug.
First Watch's Q3 2025 earnings show a revenue beat but an EPS miss. The stock faced pressure despite strong same-store sales growth of 7.1% and aggressive restaurant expansion.
Learn how a proven growth investing strategy identified Palantir (PLTR) as a top stock, highlighting its explosive earnings, sales growth, and strong cash flow.
Global Payments (GPN) reported Q3 2025 results with a slight revenue miss but solid adjusted EPS growth and a 6.4% stock rise. The company advances its transformation and Worldpay acquisition.
STRIDE INC (LRN) excels with strong revenue growth, high profitability, and exceptional capital returns, making it a top pick in the Caviar Cruise quality investing screen.
Janus Henderson Group (JHG) is a value stock trading below market multiples. It offers strong financial health, a solid 3.67% dividend yield, and steady earnings.
Discover how Phibro Animal Health (PAHC) combines strong technical trends with accelerating earnings and revenue growth, signaling a potential high-momentum investment.
